Zoetis Financial Statements From 2010 to 2024
| ZOE Stock | EUR 164.56 3.70 2.20% |
Check Zoetis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zoetis' main balance sheet or income statement drivers, such as , as well as many indicators such as . Zoetis financial statements analysis is a perfect complement when working with Zoetis Valuation or Volatility modules.
Zoetis |
Zoetis Inc Company Shares Outstanding Analysis
Zoetis' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Zoetis Shares Outstanding | 463.39 M |
Most of Zoetis' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zoetis Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Zoetis Inc has 463.39 M of shares currently outstending. This is 156.68% higher than that of the Healthcare sector and 15.38% higher than that of the Drug Manufacturers - Specialty & Generic industry. The shares outstanding for all Germany stocks is 18.96% higher than that of the company.
Zoetis Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Zoetis's current stock value. Our valuation model uses many indicators to compare Zoetis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zoetis competition to find correlations between indicators driving Zoetis's intrinsic value. More Info.Zoetis Inc is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.27 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Zoetis Inc is roughly 3.71 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zoetis' earnings, one of the primary drivers of an investment's value.About Zoetis Financial Statements
Zoetis stakeholders use historical fundamental indicators, such as Zoetis' revenue or net income, to determine how well the company is positioned to perform in the future. Although Zoetis investors may analyze each financial statement separately, they are all interrelated. For example, changes in Zoetis' assets and liabilities are reflected in the revenues and expenses on Zoetis' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Zoetis Inc. Please read more on our technical analysis and fundamental analysis pages.
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. ZOETIS INC operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10000 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Zoetis Stock
When determining whether Zoetis Inc is a strong investment it is important to analyze Zoetis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zoetis' future performance. For an informed investment choice regarding Zoetis Stock, refer to the following important reports:Check out the analysis of Zoetis Correlation against competitors. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.